JUNS
NASDAQJupiter Neurosciences Inc.
Price$0.17+0.00 (+0.53%)
01:30 PM07:45 PM
News · 26 weeks63-6%
2026-01-182026-07-12
Mix4590d
- SEC Filings20(44%)
- Insider16(36%)
- Other5(11%)
- Offering2(4%)
- Market1(2%)
- Leadership1(2%)
Latest news
25 items- INSIDERChief Administrative Officer Rosen Alexander Gustaf Erik converted options into 261,161 shares, increasing direct ownership by 73% to 617,411 units (SEC Form 4)4 - JUPITER NEUROSCIENCES, INC. (0001679628) (Issuer)
- INSIDERDirector Kampf Julie B. converted options into 82,875 shares (SEC Form 4)4 - JUPITER NEUROSCIENCES, INC. (0001679628) (Issuer)
- INSIDERDirector Weis Holger converted options into 85,800 shares, increasing direct ownership by 796% to 96,581 units (SEC Form 4)4 - JUPITER NEUROSCIENCES, INC. (0001679628) (Issuer)
- INSIDERDirector Hemmerly Nicholas H. converted options into 95,550 shares (SEC Form 4)4 - JUPITER NEUROSCIENCES, INC. (0001679628) (Issuer)
- INSIDERChief Scientific Officer Hayward Marshall A. converted options into 1,014,195 shares, increasing direct ownership by 51% to 2,995,077 units (SEC Form 4)4 - JUPITER NEUROSCIENCES, INC. (0001679628) (Issuer)
- SECSEC Form EFFECT filed by Jupiter Neurosciences Inc.EFFECT - JUPITER NEUROSCIENCES, INC. (0001679628) (Filer)
- PRJupiter Neurosciences Strengthens Board with Appointment of Dr. Tomas J. PhilipsonFormer White House Council of Economic Advisors Brings Extensive Government, Academic, and Private Sector Experience to Advance Company's Strategic Growth JUPITER, FL, July 07, 2026 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ:JUNS) ("Jupiter Neurosciences" or the "Company"), a clinical-stage biopharmaceutical company, today announced the appointment of Tomas J. Philipson, Ph.D., a distinguished health care economist and former Acting Chairman of the White House Council of Economic Advisers, to its Board of Directors, effective June 26, 2026. Dr. Philipson will serve on both the Audit Committee and Compensation Committee, bringing unparalleled expertise in health economics, reg
- INSIDERSEC Form 4 filed by Director Philipson Tomas Jan4 - JUPITER NEUROSCIENCES, INC. (0001679628) (Issuer)
- INSIDERSEC Form 3 filed by new insider Philipson Tomas Jan3 - JUPITER NEUROSCIENCES, INC. (0001679628) (Issuer)
- SECSEC Form 424B3 filed by Jupiter Neurosciences Inc.424B3 - JUPITER NEUROSCIENCES, INC. (0001679628) (Filer)
- SECJupiter Neurosciences Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - JUPITER NEUROSCIENCES, INC. (0001679628) (Filer)
- SECSEC Form S-1 filed by Jupiter Neurosciences Inc.S-1 - JUPITER NEUROSCIENCES, INC. (0001679628) (Filer)
- SECSEC Form DEF 14A filed by Jupiter Neurosciences Inc.DEF 14A - JUPITER NEUROSCIENCES, INC. (0001679628) (Filer)
- SECSEC Form 424B3 filed by Jupiter Neurosciences Inc.424B3 - JUPITER NEUROSCIENCES, INC. (0001679628) (Filer)
- SECJupiter Neurosciences Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - JUPITER NEUROSCIENCES, INC. (0001679628) (Filer)
- PRPresenting on Emerging Growth Conference 93 Day 2 on June 11; Register to live streamMIAMI, June 10, 2026 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 93rd Emerging Growth Conference on June 10 & 11, 2026. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies to: Questions@EmergingGrowth.com For updates, follow us on Twitter Presenting Today – Wednesday June 11, 2026 8:30Virtual Lobby opens.Register for the Conference. If you already registered,
- SECSEC Form PRE 14A filed by Jupiter Neurosciences Inc.PRE 14A - JUPITER NEUROSCIENCES, INC. (0001679628) (Filer)
- PRPresenting on Emerging Growth Conference 93 Day 1 on June 10; Register to live streamMIAMI, June 09, 2026 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 93rd Emerging Growth Conference on June 10 & 11, 2026. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies to: Questions@EmergingGrowth.com For updates, follow us on Twitter Day 1 - WednesdayJune 10, 2026 8:30Virtual Lobby opens.Register for the Conference. If you already registered, go back to
- SECSEC Form 424B3 filed by Jupiter Neurosciences Inc.424B3 - JUPITER NEUROSCIENCES, INC. (0001679628) (Filer)
- SECJupiter Neurosciences Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - JUPITER NEUROSCIENCES, INC. (0001679628) (Filer)
- INSIDERSEC Form 4 filed by Director Brady Allison W4 - JUPITER NEUROSCIENCES, INC. (0001679628) (Issuer)
- INSIDERSEC Form 4 filed by Chief Scientific Officer Hayward Marshall A.4 - JUPITER NEUROSCIENCES, INC. (0001679628) (Issuer)
- INSIDERSEC Form 4 filed by Chief Financial Officer Elmasri Saleem4 - JUPITER NEUROSCIENCES, INC. (0001679628) (Issuer)
- INSIDERSEC Form 4 filed by President and COO Silva Alison D.4 - JUPITER NEUROSCIENCES, INC. (0001679628) (Issuer)
- INSIDERSEC Form 4 filed by Director Kampf Julie B.4 - JUPITER NEUROSCIENCES, INC. (0001679628) (Issuer)
JUNS FAQ
5 questionsWhere does JUNS stock trade?
Jupiter Neurosciences Inc. (JUNS) is listed on NASDAQ.What sector and industry is JUNS in?
Jupiter Neurosciences Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did Jupiter Neurosciences Inc. go public?
Jupiter Neurosciences Inc. (JUNS) completed its IPO in 2024.What companies are similar to JUNS?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.), NVS (Novartis AG). Compare JUNS side-by-side with any of them on Quantisnow.How can I track JUNS on Quantisnow?
Quantisnow aggregates Jupiter Neurosciences Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow JUNS to receive live email and push alerts on every new disclosure.